Catalyst Wire Dossier Catalyst Wire Dossier

TOBRADEX Ophthalmic Suspension

tobramycin/dexamethasone ophthalmic suspension · Alcon
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TOBRADEX Ophthalmic Suspension, covering 2010-01-14 to 2010-01-14. Get the full timeline:

Most recent: Clinical Trial Update: TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension [Phase 3]

See pricing